Publication

Diabetic Ketoacidosis Precipitated by COVID-19

View document

Bibliographic Details
Summary:COVID-19 has a broad spectrum of presentation, ranging from asymptomatic to severe disease. Patients with comorbidities, such as cardiovascular and metabolic, have a higher risk of developing severe disease or even complications. COVID-19 may precipitate the onset of metabolic complications such as diabetic ketoacidosis. There have been reported cases of mild or even asymptomatic disease associated with states of ketoacidosis, and the virus may act as a precipitating factor for metabolic deterioration even in the absence of symptoms. Therefore, further clinical studies are imperative to understand the correlation between COVID-19 and diabetic ketoacidosis.
Main Authors:Barros, Carolina
Other Authors:Malheiro, Alexandra; Martins, Mariana; Correia, João Paulo; Perneta Santos, Miguel; Balza, Pedro
Subject:COVID-19 Cetoacidose Diabética SARS-CoV-2 COVID-19 Diabetic Ketoacidosis SARS-CoV-2
Year:2021
Country:Portugal
Document type:article
Access type:unknown
Associated institution:CUF
Language:Portuguese
Origin:Gazeta Médica
Description
Summary:COVID-19 has a broad spectrum of presentation, ranging from asymptomatic to severe disease. Patients with comorbidities, such as cardiovascular and metabolic, have a higher risk of developing severe disease or even complications. COVID-19 may precipitate the onset of metabolic complications such as diabetic ketoacidosis. There have been reported cases of mild or even asymptomatic disease associated with states of ketoacidosis, and the virus may act as a precipitating factor for metabolic deterioration even in the absence of symptoms. Therefore, further clinical studies are imperative to understand the correlation between COVID-19 and diabetic ketoacidosis.